Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
107,2 INR | +0,08 % |
|
+1,10 % | -13,33 % |
Resumen de negocios
Número de empleados: 296
Ventas por actividad
INR en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Formulations
91,9
%
| 1 754 | 90,4 % | 855 | 91,9 % | -51,25 % |
Bulk Drugs
3,0
%
| 82 | 4,2 % | 28 | 3,0 % | -65,50 % |
Processing Charges
2,4
%
| 79 | 4,1 % | 23 | 2,4 % | -71,36 % |
Commission
1,1
%
| 17 | 0,9 % | 10 | 1,1 % | -40,22 % |
Royalty
0,7
%
| 4 | 0,2 % | 6 | 0,7 % | +70,39 % |
Export Incentives
0,5
%
| 5 | 0,3 % | 4 | 0,5 % | -13,61 % |
Other Operating Income
0,4
%
| 0 | 0,0 % | 4 | 0,4 % | +4.940,00 % |
Ventas por región
INR en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Rest of World
52,8
%
| 535 | 29,2 % | 466 | 52,8 % | -12,95 % |
India
47,2
%
| 1 300 | 70,8 % | 417 | 47,2 % | -67,91 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 37 | 01/04/10 | |
Director of Finance/CFO | 63 | 01/07/14 | |
Kishore P. Shah
CMP | Compliance Officer | - | 09/11/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Director/Board Member | 76 | 08/08/22 | |
Chairman | 73 | 08/08/23 | |
Director of Finance/CFO | 63 | 01/07/14 | |
Chief Executive Officer | 37 | 01/04/10 | |
Dhara P. Shah
BRD | Director/Board Member | 36 | 04/08/21 |
Shashil Mendonsa
BRD | Director/Board Member | - | 08/08/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 35 690 000 | 14 386 677 ( 40,31 %) | 0 | 40,31 % |
Información de la empresa
Lyka Labs Ltd.
Ground Floor, Spencer Building 30, Forjett Street
400036, Mumbai
+91 22 6611 2200
http://www.lykalabs.com![Dirección Lyka Labs Limited(LYKALABS)](https://cdn.zonebourse.com/static/address/9743091.png)
Empresas del grupo
Nombre | Categoría y sector |
---|---|
Lyka BDR International Ltd.
![]() Lyka BDR International Ltd. Pharmaceuticals: MajorHealth Technology Lyka BDR International Ltd. manufactures and markets finished pharmaceutical formulations and ready-to-fill lyophilized sterile active pharmaceutical ingredients products. It markets formulations in various dosage forms. The firm also sells human and veterinary products in Sudan. The company was founded on July 19, 1993 and is headquartered in Mumbai, India. |
Pharmaceuticals: Major
|
Ventas por actividad
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
-13,33 % | 42,5 M | |
+54,61 % | 815 mil M | |
+44,25 % | 654 mil M | |
-6,33 % | 354 mil M | |
+20,62 % | 337 mil M | |
+10,44 % | 302 mil M | |
+18,45 % | 247 mil M | |
+2,09 % | 229 mil M | |
+13,03 % | 219 mil M | |
+8,61 % | 171 mil M |
- Bolsa de valores
- Acciones
- Acción LYKALABS
- Empresa Lyka Labs Limited